Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Ritchie (1973)
Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome 1Gut, 14
W. Whitehead, Beate Holtkotter, P. Enck, R. Hoelzl, K. Holmes, James Anthony, H. Shabsin, M. Schuster (1990)
Tolerance for rectosigmoid distention in irritable bowel syndrome.Gastroenterology, 98 5 Pt 1
S. Sikandar, A. Dickenson (2012)
Visceral pain: the ins and outs, the ups and downsCurrent Opinion in Supportive and Palliative Care, 6
R. Gomes, C. Brodskyn, C. Oliveira, J. Costa, J. Miranda, A. Caldas, J. Valenzuela, M. Barral-Netto, A. Barral (2002)
Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity.The Journal of infectious diseases, 186 10
M. Caterina, M. Schumacher, M. Tominaga, Tobias Rosen, J. Levine, D. Julius (1997)
The capsaicin receptor: a heat-activated ion channel in the pain pathwayNature, 389
B. Banerjee, B. Medda, Z. Lazarova, N. Bansal, R. Shaker, J. Sengupta (2007)
Effect of reflux‐induced inflammation on transient receptor potential vanilloid one (TRPV1) expression in primary sensory neurons innervating the oesophagus of ratsNeurogastroenterology & Motility, 19
R. Willert, C. Woolf, A. Hobson, C. Delaney, D. Thompson, Q. Aziz (2004)
The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor.Gastroenterology, 126 3
Manimozhiyan Arumugam, J. Raes, É. Pelletier, D. Paslier, Takuji Yamada, D. Mende, G. Fernandes, J. Tap, T. Bruls, Jean-Michel Batto, Marcelo Bertalan, N. Borruel, F. Casellas, Leyden Fernández, L. Gautier, T. Hansen, M. Hattori, Tetsuya Hayashi, M. Kleerebezem, K. Kurokawa, M. Leclerc, F. Levenez, C. Manichanh, H. Nielsen, T. Nielsen, N. Pons, J. Poulain, J. Qin, Thomas Sicheritz-Pontén, S. Tims, D. Torrents, Edgardo Ugarte, E. Zoetendal, Junwang, F. Guarner, O. Pedersen, W. Vos, S. Brunak, J. Doré, MetaHIT consortium, J. Weissenbach, S. Ehrlich, P. Bork (2011)
Enterotypes of the human gut microbiomeNature, 474
K. Tyler, Stéphanie Moriceau, Regina Sullivan, B. Meerveld (2007)
Long‐term colonic hypersensitivity in adult rats induced by neonatal unpredictable vs predictable shockNeurogastroenterology & Motility, 19
H. Mertz, B. Naliboff, J. Munakata, N. Niazi, E. Mayer (1995)
Altered rectal perception is a biological marker of patients with irritable bowel syndrome.Gastroenterology, 109 1
R. Spiller, R. Spiller, Qasim Aziz, F. Creed, A. Emmanuel, L. Houghton, P. Hungin, Roger Jones, D. Kumar, G. Rubin, N. Trudgill, P. Whorwell (2007)
Guidelines on the irritable bowel syndrome: mechanisms and practical managementGut, 56
Douglas Drossman (2006)
Rome III: The Functional Gastrointestinal Disorders
Ayesha Akbar, Y. Yiangou, P. Facer, Julian Walters, Praveen Anand, Subrata Ghosh (2008)
Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal painGut, 57
F. Barreau, L. Ferrier, J. Fioramonti, L. Buéno (2007)
New Insights in the Etiology and Pathophysiology of Irritable Bowel Syndrome: Contribution of Neonatal Stress ModelsPediatric Research, 62
M. Pimentel, A. Lembo, W. Chey, S. Zakko, Y. Ringel, Jing Yu, S. Mareya, Audrey Shaw, E. Bortey, W. Forbes (2011)
Rifaximin therapy for patients with irritable bowel syndrome without constipation.The New England journal of medicine, 364 1
D. Drossman (2005)
What does the future hold for irritable bowel syndrome and the functional gastrointestinal disorders?Journal of clinical gastroenterology, 39 5 Suppl 3
R. Staud, M. Rodríguez (2006)
Mechanisms of Disease: pain in fibromyalgia syndromeNature Clinical Practice Rheumatology, 2
S. Sarkar, Q. Aziz, C. Woolf, A. Hobson, D. Thompson (2000)
Contribution of central sensitisation to the development of noncardiac chest painThe Lancet, 356
W. Whitehead, B. Engel, M. Schuster (1980)
Irritable bowel syndromeDigestive Diseases and Sciences, 25
R. Levy, K. Jones, W. Whitehead, Shara Feld, N. Talley, L. Corey (2001)
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology.Gastroenterology, 121 4
Ayesha Akbar, Julian Walters, Subrata Ghosh (2009)
Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agentsAlimentary Pharmacology & Therapeutics, 30
I. Cook, A. Eeden, S. Collins (1987)
Patients with irritable bowel syndrome have greater pain tolerance than normal subjects.Gastroenterology, 93 4
Q. Aziz, J. Doré, A. Emmanuel, F. Guarner, E. Quigley (2013)
Gut microbiota and gastrointestinal health: current concepts and future directionsNeurogastroenterology & Motility, 25
C. Knowles, Q. Aziz (2007)
Visceral hypersensitivity in non-erosive reflux diseaseGut, 57
Mellar Davis (2005)
The opioid bowel syndrome: a review of pathophysiology and treatment.Journal of opioid management, 1 3
C. Wilder-Smith (2011)
The balancing act: endogenous modulation of pain in functional gastrointestinal disordersGut, 60
J. Levine, N. Alessandri‐Haber (2007)
TRP channels: targets for the relief of pain.Biochimica et biophysica acta, 1772 8
T. Robbins, C. Gillan, Dana Smith, S. Wit, K. Ersche (2012)
Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatryTrends in Cognitive Sciences, 16
N. Vergnolle, J. Wallace, N. Bunnett, M. Hollenberg (2001)
Protease-activated receptors in inflammation, neuronal signaling and pain.Trends in pharmacological sciences, 22 3
Ture Ålander, G. Heimer, K. Svärdsudd, L. Agréus (2007)
Abuse in Women and Men with and without Functional Gastrointestinal DisordersDigestive Diseases and Sciences, 53
I. Gottesman, T. Gould (2003)
The endophenotype concept in psychiatry: etymology and strategic intentions.The American journal of psychiatry, 160 4
S. Sarkar, A. Hobson, A. Hughes, J. Growcott, C. Woolf, D. Thompson, Q. Aziz (2003)
The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans.Gastroenterology, 124 1
K. Tillisch, E. Mayer (2005)
Pain Perception in Irritable Bowel SyndromeCNS Spectrums, 10
G. Verne, N. Himes, M. Robinson, K. Gopinath, R. Briggs, B. Crosson, D. Price (2003)
Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndromePAIN®, 103
K. Wingenfeld, C. Heim, I. Schmidt, D. Wagner, G. Meinlschmidt, D. Hellhammer (2008)
HPA Axis Reactivity and Lymphocyte Glucocorticoid Sensitivity in Fibromyalgia Syndrome and Chronic Pelvic PainPsychosomatic Medicine, 70
E. Mayer, Q. Aziz, S. Coen, M. Kern, J. Labus, R. Lane, B. Kuo, B. Naliboff, I. Tracey (2009)
Brain imaging approaches to the study of functional GI disorders: A Rome Working Team ReportNeurogastroenterology & Motility, 21
D. Holschneider, S. Bradesi, E. Mayer (2011)
The role of experimental models in developing new treatments for irritable bowel syndromeExpert Review of Gastroenterology & Hepatology, 5
P. Paine, Jessin Kishor, S. Worthen, L. Gregory, Q. Aziz (2009)
Exploring relationships for visceral and somatic pain with autonomic control and personalityPAIN®, 144
S. Dunlop, D. Jenkins, K. Neal, R. Spiller (2003)
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.Gastroenterology, 125 6
A. Farmer, E. Ferdinand, Q. Aziz (2013)
Opioids and the Gastrointestinal Tract - A Case of Narcotic Bowel Syndrome and Literature ReviewJournal of Neurogastroenterology and Motility, 19
D. Drossman (2013)
Faculty Opinions recommendation of Intestinal microbiota in functional bowel disorders: a Rome foundation report.
Q. Aziz, C. Botha, R. Willert (2010)
Pharmacology of Visceral Pain: Central FactorsDigestive Diseases, 27
T. Dinan, E. Quigley, Salah Ahmed, P. Scully, S. O'Brien, L. O’Mahony, S. O'Mahony, F. Shanahan, P. Keeling (2006)
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?Gastroenterology, 130 2
S. Wanrooij, M. Wouters, L. Oudenhove, Winde Vanbrabant, S. Mondelaers, Patrick Kollmann, Florian Kreutz, M. Schemann, G. Boeckxstaens (2014)
Sensitivity Testing in Irritable Bowel Syndrome With Rectal Capsaicin Stimulations: Role of TRPV1 Upregulation and Sensitization in Visceral Hypersensitivity?The American Journal of Gastroenterology, 109
S. Vanner, B. Meerveld, G. Mawe, T. Shea-Donohue, E. Verdú, J. Wood, D. Grundy (2006)
Fundamentals of Neurogastroenterology: Basic Science.Gastroenterology
N. Zárate, A. Farmer, R. Grahame, S. Mohammed, C. Knowles, S. Scott, Q. Aziz (2010)
Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link?Neurogastroenterology & Motility, 22
J. Winston, M. Shenoy, D. Medley, A. Naniwadekar, P. Pasricha (2007)
The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats.Gastroenterology, 132 2
E. Corazziari (2004)
Definition and epidemiology of functional gastrointestinal disorders.Best practice & research. Clinical gastroenterology, 18 4
S. Elsenbruch, C. Rosenberger, U. Bingel, M. Forsting, M. Schedlowski, E. Gizewski (2010)
Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli.Gastroenterology, 139 4
A. Garg, J. Macnab, W. Clark, J. Ray, J. Marshall, R. Suri, P. Devereaux, B. Haynes (2005)
Long-term health sequelae following E. coli and campylobacter contamination of municipal water. Population sampling and assessing non-participation biases.Canadian journal of public health = Revue canadienne de sante publique, 96 2
K. Tillisch, E. Mayer, J. Labus (2011)
Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome.Gastroenterology, 140 1
A. Farmer, S. Coen, S. Coen, M. Kano, M. Kano, H. Naqvi, P. Paine, P. Paine, S. Scott, P. Furlong, S. Lightman, C. Knowles, Q. Aziz (2014)
Psychophysiological responses to visceral and somatic pain in functional chest pain identify clinically relevant pain clustersNeurogastroenterology & Motility, 26
A. Hungin, P. Whorwell, J. Tack, F. Mearin (2003)
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjectsAlimentary Pharmacology & Therapeutics, 17
K. DeVault, D. Castell (1992)
The irritable stomach syndrome.The American journal of gastroenterology, 87 3
L. Blackshaw, G. Gebhart (2002)
The pharmacology of gastrointestinal nociceptive pathways.Current opinion in pharmacology, 2 6
I. Nasr, A. Attaluri, E. Coss-Adame, S. Rao (2012)
Diagnostic utility of the oesophageal balloon distension test in the evaluation of oesophageal chest painAlimentary Pharmacology & Therapeutics, 35
N. Vergnolle (2008)
Postinflammatory visceral sensitivity and pain mechanismsNeurogastroenterology & Motility, 20
R. Leadley, N. Armstrong, Yvonne Lee, A. Allen, J. Kleijnen (2012)
Chronic Diseases in the European Union: The Prevalence and Health Cost Implications of Chronic PainJournal of Pain & Palliative Care Pharmacotherapy, 26
P. Anand, Q. Aziz, R. Willert, L. Oudenhove, L. Oudenhove (2007)
Peripheral and central mechanisms of visceral sensitization in manNeurogastroenterology & Motility, 19
Yuri Saito, J. Zimmerman, W. Harmsen, M. Andrade, G. Locke, G. Petersen, N. Talley (2008)
Irritable bowel syndrome aggregates strongly in families: a family‐based case‐control studyNeurogastroenterology & Motility, 20
J. Zeitoun, J. Lefèvre, V. Parades, C. Séjourné, I. Sobhani, B. Coffin, C. Hamonet (2013)
Functional Digestive Symptoms and Quality of Life in Patients with Ehlers-Danlos Syndromes: Results of a National Cohort Study on 134 PatientsPLoS ONE, 8
N. Mazurak, N. Seredyuk, Helene Sauer, M. Teufel, P. Enck (2012)
Heart rate variability in the irritable bowel syndrome: a review of the literatureNeurogastroenterology & Motility, 24
Shaoyong Yu, A. Ouyang (2009)
TRPA1 in bradykinin-induced mechanical hypersensitivity of vagal C fibers in guinea pig esophagus.American journal of physiology. Gastrointestinal and liver physiology, 296 2
C. Knowles, Q. Aziz (2009)
Basic and clinical aspects of gastrointestinal painPAIN, 141
J. Leserman, D. Drossman (2007)
Relationship of Abuse History to Functional Gastrointestinal Disorders and SymptomsTrauma, Violence, & Abuse, 8
R. Jones, Linjing Xu, G. Gebhart (2005)
The Mechanosensitivity of Mouse Colon Afferent Fibers and Their Sensitization by Inflammatory Mediators Require Transient Receptor Potential Vanilloid 1 and Acid-Sensing Ion Channel 3The Journal of Neuroscience, 25
L. Blackshaw, S. Brierley, P. Hughes, A. Harrington (2011)
The hot mustard receptor's role in gut motor function.Gastroenterology, 141 2
C. Knowles, R. Giorgio, R. Kapur, E. Bruder, G. Farrugia, K. Geboes, G. Lindberg, Joanne Martin, W. Meier-Ruge, P. Milla, V. Smith, Jean Vandervinden, B. Veress, T. Wedel (2010)
The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working GroupGut, 59
R. Edwards (2005)
Individual differences in endogenous pain modulation as a risk factor for chronic painNeurology, 65
H. Quiding, B. Jonzon, O. Svensson, L. Webster, Annika Reimfelt, Aleksandra Karin, R. Karlsten, M. Segerdahl (2013)
TRPV1 antagonistic analgesic effect: A randomized study of AZD1386 in pain after third molar extractionPAIN®, 154
M. Corsetti, Jan Tack (2013)
FDA and EMA end points: which outcome end points should we use in clinical trials in patients with irritable bowel syndrome?Neurogastroenterology & Motility, 25
D. Drossman, Zhiming Li, E. Andruzzi, R. Temple, N. Talley, W. Thompson, W. Whitehead, J. Janssens, P. Funch-Jensen, E. Corazziari, J. Richter, G. Koch (1993)
U. S. Householder survey of functional gastrointestinal disordersDigestive Diseases and Sciences, 38
A. Mikocka‐Walus, D. Turnbull, N. Moulding, Ian Wilson, J. Andrews, G. Holtmann (2008)
Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patientsJournal of Gastroenterology and Hepatology, 23
A. Krarup, Lars Ny, Magnus Åstrand, A. Bajor, F. hvid-Jensen, Mark Hansen, Magnus Simrén, Peter Funch-Jensen, A. Drewes (2011)
Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal painAlimentary Pharmacology & Therapeutics, 33
M. Bouin, P. Meunier, M. Riberdy-Poitras, P. Poitras (2001)
Pain Hypersensitivity in Patients with Functional Gastrointestinal Disorders: A Gastrointestinal-Specific Defect or a General Systemic Condition?Digestive Diseases and Sciences, 46
K. Mossman (2008)
The Wellcome Trust Case Control Consortium, U.K.Scientific American, 298
Marc Lémann, J. Dederding, Bernard Flourié, C. Franchisseur, J. Rambaud, Raymond Jian (1991)
Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsiaDigestive Diseases and Sciences, 36
U. Ghoshal, Prabhat Ranjan (2011)
Post‐infectious irritable bowel syndrome: The past, the present and the futureJournal of Gastroenterology and Hepatology, 26
J. Rioux, J. Rioux, R. Xavier, K. Taylor, M. Silverberg, P. Goyette, A. Huett, Todd Green, Petric Kuballa, M. Barmada, L. Datta, Y. Shugart, A. Griffiths, S. Targan, A. Ippoliti, E. Bernard, L. Mei, D. Nicolae, M. Regueiro, L. Schumm, A. Steinhart, J. Rotter, R. Duerr, Judy Cho, M. Daly, M. Daly, S. Brant (2007)
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesisNature Genetics, 39
P. Holzer (2004)
TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia.European journal of pharmacology, 500 1-3
A. Salonen, W. Vos, A. Palva (2010)
Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives.Microbiology, 156 Pt 11
(2002)
Prognosis in post-infective irritable bowel syndrome: a six year follow up study
K. Gwee, N. Read, J. Graham, M. Mckendrick, S. Collins, J. Marshall, S. Walters (1996)
Psychometric scores and persistence of irritable bowel after infectious diarrhoeaThe Lancet, 347
R. Landis (2007)
Protease activated receptors: clinical relevance to hemostasis and inflammation.Hematology/oncology clinics of North America, 21 1
A. Garg, J. Macnab, W. Clark, J. Ray, J. Marshall, R. Suri, P. Devereaux, B. Haynes, On Investigators (2005)
Long-term Health Sequelae Following E.coli and Campylobacter Contamination of Municipal WaterCanadian Journal of Public Health, 96
I. Jeffery, P. O’Toole, L. Öhman, M. Claesson, J. Deane, E. Quigley, M. Simrén (2011)
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiotaGut, 61
S. Mohammed, P. Lunniss, N. Zárate, A. Farmer, R. Grahame, Q. Aziz, S. Scott (2010)
Joint hypermobility and rectal evacuatory dysfunction: an etiological link in abnormal connective tissue?Neurogastroenterology & Motility, 22
P. Eckburg, E. Bik, C. Bernstein, E. Purdom, L. Dethlefsen, Michael Sargent, S. Gill, K. Nelson, D. Relman (2005)
Diversity of the Human Intestinal Microbial FloraScience, 308
A. Montiel-Castro, R. González-Cervantes, Gabriela Bravo-Ruiseco, G. Pacheco-López (2013)
The microbiota-gut-brain axis: neurobehavioral correlates, health and socialityFrontiers in Integrative Neuroscience, 7
G. Mells, J. Floyd, K. Morley, H. Cordell, C. Franklin, S. Shin, M. Heneghan, J. Neuberger, P. Donaldson, Darren Day, S. Ducker, A. Muriithi, Elizabeth Wheater, C. Hammond, M. Dawwas, David Jones, L. Peltonen, G. Alexander, R. Sandford, C. Anderson (2011)
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosisNature genetics, 43
W. Han, Zhengping Wang, X. Lu, C. Guo (2012)
Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndromeNeurogastroenterology & Motility, 24
L. Öhman, M. Simrén (2007)
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 39 3
S. Asfaha, N. Cenac, S. Houle, C. Altier, M. Papez, C. Nguyen, M. Steinhoff, K. Chapman, G. Zamponi, N. Vergnolle (2007)
Protease‐activated receptor‐4: a novel mechanism of inflammatory pain modulationBritish Journal of Pharmacology, 150
P. Bercik (2011)
The microbiota–gut–brain axis: learning from intestinal bacteria?Gut, 60
Michael Jones, J. Dilley, D. Drossman, M. Crowell (2006)
Brain–gut connections in functional GI disorders: anatomic and physiologic relationshipsNeurogastroenterology & Motility, 18
N. Vergnolle (2004)
Modulation of visceral pain and inflammation by protease‐activated receptorsBritish Journal of Pharmacology, 141
D. Keszthelyi, F. Troost, A. Masclee (2012)
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome.American journal of physiology. Gastrointestinal and liver physiology, 303 2
D. Grunkemeier, J. Cassara, C. Dalton, D. Drossman (2007)
The narcotic bowel syndrome: clinical features, pathophysiology, and management.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 5 10
Y. Chua, K. Ng, Abhishek Sharma, Jafar Jafari, S. Surguy, Etsuro Yazaki, Charles Knowles, Qasim Aziz (2012)
Randomised clinical trial: pregabalin attenuates the development of acid‐induced oesophageal hypersensitivity in healthy volunteers – a placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 35
K. Tillisch, E. Mayer, J. Labus, J. Stains, Lin Chang, B. Naliboff (2005)
Sex specific alterations in autonomic function among patients with irritable bowel syndromeGut, 54
(1959)
O'Brien's
A. Farmer, M. Kano, S. Coen, Q. Aziz (2011)
Psychophysiological responses to oesophageal stimulation in functional chest pain: a case control studyGut, 60
Ahmed Othman, W. Nothaft, W. Awni, S. Dutta (2012)
Pharmacokinetics of the TRPV1 Antagonist ABT‐102 in Healthy Human Volunteers: Population Analysis of Data From 3 Phase 1 TrialsThe Journal of Clinical Pharmacology, 52
C. Knowles, R. Giorgio, R. Kapur, E. Bruder, G. Farrugia, K. Geboes, M. Gershon, John Hutson, G. Lindberg, Joanne Martin, W. Meier-Ruge, P. Milla, V. Smith, Jean Vandervinden, B. Veress, T. Wedel (2009)
Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working GroupActa Neuropathologica, 118
Yuri Saito, N. Talley, L. Melton, S. Fett, A. Zinsmeister, G. Locke (2000)
The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimatesNeurogastroenterology & Motility, 15
A. Hakim, R. Keer, R. Grahame (2010)
Hypermobility, fibromyalgia and chronic pain
I. Tracey (2011)
Can neuroimaging studies identify pain endophenotypes in humans?Nature Reviews Neurology, 7
A. Sharma, P. Paine, S. Rhodes, F. Warburton, Y. Chua, Q. Aziz (2012)
The autonomic response to human esophageal acidification and the development of hyperalgesiaNeurogastroenterology & Motility, 24
AbstractBackground and aimsChronic visceral pain is common both in patients with identifiable organic disease and also in those without any structural, biochemical or immunological abnormality such as in the functional gastrointestinal disorders (FGIDs). We aim to provide a contemporaneous summary of pathways involved in visceral nociception and how a variety of mechanisms may influence an individual’s experience of visceral pain.MethodsIn this narrative review, we have brought together evidence through a detailed search of Medline in addition to using our experience and exposure to recent research developments from ourselves and other research groups.ResultsFGIDs are a heterogeneous group of disorders whose aetiology largely remains an enigma. The germane hypothesis for the genesis and maintenance of chronic visceral pain in FGIDs is the concept of visceral hypersensitivity. A number of peripheral and central mechanisms have been proposed to account for this epiphenomenon. In the periphery, inflammatory mediators activate and sensitize nociceptive afferent nerves by reducing their transduction thresholds and by inducing the expression and recruitment of hitherto silent nociceptors culminating in an increase in pain sensitivity at the site of injury known as primary hyperalgesia. Centrally, secondary hyperalgesia, defined as an increase in pain sensitivity in anatomically distinct sites, occurs at the level of the spinal dorsal horn. Moreover, the stress responsive physiological systems, genetic and psychological factors may modulate the experience of visceral pain. We also address some novel aetiological concepts in FGIDs, namely the gastrointestinal microbiota, connective tissue abnormalities and the gastrointestinal neuromuscular disorders. Firstly, the gastrointestinal microbiota is a diverse and dynamic ecosystem, that safeguards the host from external pathogens, aids in the metabolism of polysaccharides and lipids, modulates intestinal motility, in addition to modulating visceral perception. Secondly, connective tissue disorders, which traditionally have been considered to be confined largely to the musculoskeletal system, have an increasing evidence base demonstrating the presence of visceral manifestations. Since the sensorimotor apparatus of the GI tract is embedded within connective tissue it should not be surprising that such disorder may result in visceral pain and abnormal gut motility. Thirdly, gastrointestinal neuromuscular diseases refer to a heterogeneous group of disorders in which symptoms arise from impaired GI motor activity often manifesting as abnormal transit with or without radiological evidence of transient or persistent dilation of the viscera. Although a number of these are readily recognizable, such as achalasia or Hirschsprung’s disease, the cause in a number of patients is not. An international working group has recently addressed this “gap”, providing a comprehensive morphologically based diagnostic criteria.Conclusions/implicationsAlthough marked advances have been made in understanding the mechanisms that contribute to the development and maintenance of visceral pain, many interventions have failed to produce tangible improvement in patient outcomes. In the last part of this review we highlight an emerging approach that has allowed the definition and delineation of temporally stable visceral pain clusters, which may improve participant homogeneity in future studies, potentially facilitate stratification of treatment in FGID and lead to improvements in diagnostic criteria and outcomes.
Scandinavian Journal of Pain – de Gruyter
Published: Apr 1, 2014
Keywords: Visceral pain; Visceral hypersensitivity; Brain–gut axis; Pain clusters
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.